NeoGenomics (United States)

NeoGenomics (United States)

NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for NeoGenomics (United States), United States, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

44%


Total
Publications

460


Total Open
Publications

203


Total
Citations

6.5K


Open Access
Percentage

44%


Total
Publications

460


Total Open
Publications

203


Total
Citations

6.5K

Wikipedia

Website

download

Breakdown

18% 20% 4% 58%

Publisher Open

18%

Both

20%

Other Platform Open

4%

Closed

58%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

010203040506070Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

37%OA Journal

OA Journal 37%

63

Hybrid 24%

41

No Guarantees 39%

65

Other Platform Open

Domain 81%

91

Institution 17%

19

Other Internet 12%

13

Preprint 7%

8

Public 2%

2

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
91
DOI
Other Internet
13
Research Square
Preprint
5
Le Centre pour la Communication Scientifique Directe - HAL - Diderot
Institution
5
Europe PMC
Domain
4
Elsevier - Scopus
Institution
4
University of Southern Denmark - University of Southern Denmark Research Portal
Institution
2
University of Bristol - Bristol Research
Institution
2
U.S. Department of Energy Office of Scientific and Technical Information - OSTI OAI
Institution
2
Figshare
Public
2
1 / 3

Data updated 18 August 2025

Share

Share

Share